Orion Corporation

Overview

Orion Corporation is a Finnish pharmaceutical company specializing in the discovery, development, and manufacturing of pharmaceuticals. It focuses on several therapeutic areas and produces both prescription medicines and self-care products.

Core services & business areas

Therapeutic areas

Active pharmaceutical ingredients supplied

Substances Orion Corporation is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Orion Corporation holds 0 active (29 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• DEXMEDETOMIDINEInactive1991-07-18
• TRIAZOLAMInactive1991-06-26
• FAVOXATE HCLInactive1989-01-16
• TERFENADINEInactive1988-12-08
• PENTOXIFYLLINEInactive1988-10-04
• SELENIUM SULFIDEInactive1987-11-10
• MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN FINLAND.Inactive1987-03-03
• PRAZOSIN HCL ALPHA-FORMInactive1987-02-18
• PRAZOSIN HCL DELTA-FORMInactive1987-02-18
• MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MANKKAA PLANT.Inactive1987-01-26
• TOLMETIN SODIUMInactive1986-12-19
• MINOXIDILInactive1986-06-25
• CHLORHEXIDINE DIHYDROCHLORIDE BP 80Inactive1986-03-19
• BENZTROPINE MESYLATEInactive1986-01-30
• RITODRINE HCLInactive1986-01-03

Showing 15 of 29 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Orion Corporation in our records. PharmaTek screens the full directory against live FDA enforcement data.